Anavex Life Sciences Stock Performance
| AVXL Stock | USD 9.46 0.43 4.76% |
On a scale of 0 to 100, Anavex Life holds a performance score of 15. The firm shows a Beta (market volatility) of 2.21, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Anavex Life will likely underperform. Please check Anavex Life's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Anavex Life's price patterns will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Anavex Life Sciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Anavex Life disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 4.76 | Five Day Return (0.63) | Year To Date Return 56.36 | Ten Year Return 1.1 K | All Time Return 18.25 |
Last Split Factor 1:4 | Last Split Date 2015-10-07 |
1 | Earnings call Merck reports robust growth in Q3 2024 with strong sales | 11/15/2024 |
2 | Deutsche Bank raises Diploma shares target, buy rating on robust growth | 11/20/2024 |
3 | Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIbIII Data in a Reference Alzheimers Disease Journal | 11/25/2024 |
4 | Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimers ... | 11/26/2024 |
5 | Commerce Cloud Market to Propel Growth at USD 143.68 Billion by 2031 SkyQuest Technology | 11/27/2024 |
| Begin Period Cash Flow | 149.2 M |
Anavex |
Anavex Life Relative Risk vs. Return Landscape
If you would invest 546.00 in Anavex Life Sciences on September 2, 2024 and sell it today you would earn a total of 400.00 from holding Anavex Life Sciences or generate 73.26% return on investment over 90 days. Anavex Life Sciences is currently generating 0.9763% in daily expected returns and assumes 4.9299% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Anavex, and 81% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Anavex Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anavex Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Anavex Life Sciences, and traders can use it to determine the average amount a Anavex Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.198
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AVXL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.93 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.98 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Anavex Life is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anavex Life by adding it to a well-diversified portfolio.
Anavex Life Fundamentals Growth
Anavex Stock prices reflect investors' perceptions of the future prospects and financial health of Anavex Life, and Anavex Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Anavex Stock performance.
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 663.41 M | ||||
| Shares Outstanding | 84.8 M | ||||
| Price To Earning | (11.03) X | ||||
| Price To Book | 6.18 X | ||||
| EBITDA | (47.5 M) | ||||
| Net Income | (47.51 M) | ||||
| Cash And Equivalents | 149.16 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 12.53 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.95 X | ||||
| Book Value Per Share | 1.53 X | ||||
| Cash Flow From Operations | (27.79 M) | ||||
| Earnings Per Share | (0.51) X | ||||
| Market Capitalization | 802.17 M | ||||
| Total Asset | 154.39 M | ||||
| Retained Earnings | (293.07 M) | ||||
| Working Capital | 141.85 M | ||||
| Current Asset | 9.45 M | ||||
| Current Liabilities | 3.19 M | ||||
About Anavex Life Performance
By examining Anavex Life's fundamental ratios, stakeholders can obtain critical insights into Anavex Life's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Anavex Life is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.29) | |
| Return On Capital Employed | (0.45) | (0.43) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.39) | (0.40) |
Things to note about Anavex Life Sciences performance evaluation
Checking the ongoing alerts about Anavex Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Anavex Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Anavex Life Sciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (47.51 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Anavex Life Sciences currently holds about 149.16 M in cash with (27.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91. | |
| Anavex Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Commerce Cloud Market to Propel Growth at USD 143.68 Billion by 2031 SkyQuest Technology |
- Analyzing Anavex Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Anavex Life's stock is overvalued or undervalued compared to its peers.
- Examining Anavex Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Anavex Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Anavex Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Anavex Life's stock. These opinions can provide insight into Anavex Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.